2018 · MOLECULAR AND BIOCHEMICAL PARASITOLOGY

Circulating cell-free DNA in patients with alveolar echinococcosis

Baraquin, Alice, Hervouet, Eric, Richou, Carine, Flori, Pierre, Peixoto, Paul, Azizi, Amel, Delabrousse, Eric, Blagosklonov, Oleg, Umhang, Gerald, Bresson-Hadni, Solange, Valot, Benoit, Grenouillet, Frederic, Felix, Sophie, Heyd, Bruno, Mantion, Georges, Di Martino, Vincent, Montange, Damien, Vanlemmens, Claire, Vuitton, Dominique Angele, Weil-Verhoeven, Delphine, Chavanet, Pascal, Dalle, Frederic, Gohier, Sandrine, Minello, Anne, Piroth, Lionel, Dumortier, Jerome, Mabrut, Jean-Yves, Wallon, Martine, Frentiu, Emilia, Machouart, Marie, Watelet, Jerome, Chemla, Cathy, Feron, Thomas, Heurge-Berlot, Alexandra, Sommacale, Daniele, Thiefin, Gerard, Abou-Bacar, Ahmed, Brunet, Julie, Candolfi, Erman, Hansmann, Yves, Lefebvre, Nicolas, EchinoVista Study Grp

Journal
MOLECULAR AND BIOCHEMICAL PARASITOLOGY
Année
2018
Volume
222
Pages
14-20
Mois
JUN
DOI
10.1016/j.molbiopara.2018.04.004

Abstract

Alveolar echinococcosis (AE) is a parasitic disease, due to Echinococcus multilocularis. Often compared to liver cancer, it develops by infiltration from its primary site to the surrounding tissue, and can then metastasize to other organs. Detection of circulating cell-free DNA (ccfDNA) is a useful analytical tool in oncology, for diagnosis, prognosis, and therapy monitoring. This study sought to investigate the presence of ccfDNA in patients with AE, and its potential usefulness for the evaluation of treatment efficiency. To achieve these aims, a quantitative PCR and a droplet digital PCR were developed to detect E. multilocularis ccfDNA. An AE animal model identified, for the first time, the presence of large quantities of ccfDNA. Samples from patients with AE (n = 31) were then analyzed twice, at diagnosis, and after three months of chemotherapy: about 25% were positive, almost always with very low concentrations of ccfDNA. These results confirmed that E. multilocularis produces ccfDNA, as solid tumors do, but detection may not yet be sufficient for AE diagnosis nor for the evaluation of treatment efficiency, due to the low levels of ccfDNA detected in patient serum.

Lire l'article complet